Company
Forte Biosciences, Inc. (FBRX)
Standardized SEC financial data for Forte Biosciences, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001419041 · NASDAQ · Pharmaceutical Preparations.
Revenue growth (YoY)
-99.8%
Return on equity
-113.8%
ROIC
-545.4%
Free cash flow
-$51.0M
Debt / equity
0.43×
Current ratio
3.88×
EPS (diluted)
$-4.71
Ratios for fiscal year 2019, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $10.0M | $13.9M | $5.6M | $21.9M | $20.7M | $57.6M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $58.8M | $42.0M | $41.1M | $37.1M | $58.4M | $77.0M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$18.4M | -$16.7M | -$8.2M | -$28.7M | -$30.7M | -$50.9M |
| Capital expenditures |
Get FBRX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/FBRX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/FBRX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"